Movement of an organism or entity in response to a chemical stimulus
Chemotaxis (from chemo- + taxis) is the movement of an organism or entity in response to a chemical stimulus.[1]Somatic cells, bacteria, and other single-cell or multicellular organisms direct their movements according to certain chemicals in their environment. This is important for bacteria to find food (e.g., glucose) by swimming toward the highest concentration of food molecules, or to flee from poisons (e.g., phenol). In multicellular organisms, chemotaxis is critical to early development (e.g., movement of sperm towards the egg during fertilization) and development (e.g., migration of neurons or lymphocytes) as well as in normal function and health (e.g., migration of leukocytes during injury or infection).[2] In addition, it has been recognized that mechanisms that allow chemotaxis in animals can be subverted during cancermetastasis,[3] and the aberrant change of the overall property of these networks, which control chemotaxis, can lead to carcinogenesis.[4] The aberrant chemotaxis of leukocytes and lymphocytes also contribute to inflammatory diseases such as atherosclerosis, asthma, and arthritis.[5][6][7][8] Sub-cellular components, such as the polarity patch generated by mating yeast, may also display chemotactic behavior.[9]
Positive chemotaxis occurs if the movement is toward a higher concentration of the chemical in question; negative chemotaxis if the movement is in the opposite direction. Chemically prompted kinesis (randomly directed or nondirectional) can be called chemokinesis.
^Planagumà A, Domènech T, Pont M, Calama E, García-González V, López R, et al. (October 2015). "Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation". Pulmonary Pharmacology & Therapeutics. 34: 37–45. doi:10.1016/j.pupt.2015.08.002. PMID26271598.
^Rana AK, Li Y, Dang Q, Yang F (December 2018). "Monocytes in rheumatoid arthritis: Circulating precursors of macrophages and osteoclasts and, their heterogeneity and plasticity role in RA pathogenesis". International Immunopharmacology. 65: 348–359. doi:10.1016/j.intimp.2018.10.016. PMID30366278. S2CID53116963.